nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.874	1	CbGbCtD
Nitrofurantoin—Methaemoglobinaemia—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0983	CcSEcCtD
Nitrofurantoin—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.00731	0.0581	CcSEcCtD
Nitrofurantoin—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00721	0.0573	CcSEcCtD
Nitrofurantoin—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00529	0.042	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0408	CcSEcCtD
Nitrofurantoin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0408	CcSEcCtD
Nitrofurantoin—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0377	CcSEcCtD
Nitrofurantoin—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0374	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0271	CcSEcCtD
Nitrofurantoin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0248	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0241	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0222	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0205	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0189	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0185	CcSEcCtD
Nitrofurantoin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0181	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0158	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0151	CcSEcCtD
Nitrofurantoin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0145	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0144	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0137	CcSEcCtD
Nitrofurantoin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00164	0.013	CcSEcCtD
Nitrofurantoin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0128	CcSEcCtD
Nitrofurantoin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0124	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0117	CcSEcCtD
Nitrofurantoin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0117	CcSEcCtD
Nitrofurantoin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0114	CcSEcCtD
Nitrofurantoin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0114	CcSEcCtD
Nitrofurantoin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0113	CcSEcCtD
Nitrofurantoin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00139	0.011	CcSEcCtD
Nitrofurantoin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0108	CcSEcCtD
Nitrofurantoin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0108	CcSEcCtD
Nitrofurantoin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0106	CcSEcCtD
Nitrofurantoin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0104	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0103	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0101	CcSEcCtD
Nitrofurantoin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00983	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00939	CcSEcCtD
Nitrofurantoin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00926	CcSEcCtD
Nitrofurantoin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00919	CcSEcCtD
Nitrofurantoin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00917	CcSEcCtD
Nitrofurantoin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00908	CcSEcCtD
Nitrofurantoin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00896	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0089	CcSEcCtD
Nitrofurantoin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00882	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0085	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00843	CcSEcCtD
Nitrofurantoin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00815	CcSEcCtD
Nitrofurantoin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00815	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000956	0.0076	CcSEcCtD
Nitrofurantoin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000931	0.0074	CcSEcCtD
Nitrofurantoin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00705	CcSEcCtD
Nitrofurantoin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000858	0.00682	CcSEcCtD
Nitrofurantoin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000825	0.00656	CcSEcCtD
Nitrofurantoin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000818	0.0065	CcSEcCtD
Nitrofurantoin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00646	CcSEcCtD
Nitrofurantoin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000771	0.00612	CcSEcCtD
